It is another interesting development. With the FDA pushing and Trump's new legislation, the goal posts are ever so slowly moving. Maybe some of the new treatments, including IMP321 may get the green light to go ahead. Interestingly, I guess he was talking about Keytruda, for approved drugs to proceed when combined with experimental drugs. We may well be very pleased we entered into the collaboration with GSK.
Right to Try Legislation in the USA., page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
-0.005(1.09%) |
Mkt cap ! $540.9M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.5¢ | 44.0¢ | $1.250M | 2.760M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 72517 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 32110 | 4 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
45.3¢ |
Change
-0.005 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 46.0¢ | 46.0¢ | 44.0¢ | 589940 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| IMM (ASX) Chart |